Operator: Greetings ladies and gentlemen. And welcome to Personalis’ First Quarter 2023 Earnings Conference Call. [Operator instructions] As a reminder this conference is being recorded.
Personalis, (PSNL) ABRCC and Criterium Announce Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.